IMNN
Imunon, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- A Apr 17 Maxim Group initiates
- R Jun 4 Imunon entered into a $10M financing with Streeterville Capital, con…
- S Jun 29 to Jul 6 2 days of insider sells: $22.4K by 1 insider, avg $1.76
- S Jul 20 1 insider sell $3.8K at $1.78
- S Aug 3 1 insider sell $4.0K at $1.57
- S Aug 17 1 insider sell $4.0K at $1.63
- S Aug 31 1 insider sell $3.9K at $1.56
- X Sep 15 Short interest jumps 114.2% to 193.6K
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $38.2K.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 1 trimmed or exited.
- EstimatesRISING
Current-quarter EPS estimate −$0.605 → −$0.550 over 90 days. 2 up, 0 down in 30 days.
- TrendDOWNTREND
10% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $9.3K |
| MORGAN STANLEY | TRIM | $2.8K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $97.6K |
| UBS Group AG | TRIM | $1.7K |
| GROUP ONE TRADING LLC | TRIM | $18.00 |
| OSAIC HOLDINGS, INC. | DOUBLED | $5.00 |
| VANGUARD GROUP INC | ADD | $141.2K |
| MORGAN STANLEY | TRIM | $11.3K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Apr 2026Price is below the lowest target. Median implies +957%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Apr 17, 2026 | Maxim Group INITIATE | Buy |
| May 19, 2025 | D. Boral Capital DOWNGRADE | Hold |
| May 13, 2025 | D. Boral Capital MAINTAIN | Buy |
| May 7, 2025 | D. Boral Capital MAINTAIN | Buy |
| Mar 26, 2025 | HC Wainwright & Co. REITERATE | Buy |
| Mar 24, 2025 | D. Boral Capital MAINTAIN | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 9, 2026 | Tardugno Michael H Executive Chairman of Board | AWARD | $8.4K |
| Oct 9, 2026 | Lindborg Stacy President and CEO | AWARD | $3.2K |
| Oct 9, 2026 | Faller Douglas Vincent Chief Medical Officer | AWARD | $1.3K |
| Sep 25, 2026 | Tardugno Michael H Executive Chairman of Board | AWARD | $10.1K |
| Sep 25, 2026 | Lindborg Stacy President and CEO | AWARD | $9.4K |
| Sep 25, 2026 | Faller Douglas Vincent Chief Medical Officer | AWARD | $6.2K |
| Sep 11, 2026 | Faller Douglas Vincent Chief Medical Officer | AWARD | $6.2K |
| Sep 11, 2026 | Lindborg Stacy President and CEO | AWARD | $8.1K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.55 | -$0.71–-$0.45 | +0.0% | $0.00 |
| Next Q | -$0.48 | -$0.71–-$0.24 | +0.0% | $0.00 |
| Current FY | -$2.33 | -$2.89–-$1.74 | +0.0% | $0.00 |
| Next FY | -$1.77 | -$3.03–-$1.06 | +0.0% | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
12 filings · 1 press release · 1 bullish · 3 bearish · 1 mixed · 7 neutral- BEARISH S-1Oct 27, 2026
Imunon filed an S-1 registration for a best-efforts offering of up to 20M shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 70M additional shares, representing 350% warrant coverage. The company also disclosed an asset purchase agreement to sell its…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 8-KOct 27, 2026
Imunon filed an 8-K to announce that it made an investor presentation available for use in investor calls and conferences. The filing is a routine disclosure of marketing materials with no new material financial or operational information.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 8-KOct 21, 2026
Imunon entered into an asset purchase agreement to sell its ThermoDox program to VoxelDox…
The deal provides no near-term capital for Imunon. Monitor VoxelDox's ability to close the $2.5 million financing, as the transaction collapses without it. Imunon's stock will trade on the progress…
- BEARISH 8-KSep 29, 2026
Imunon (IMNN) exchanged $1.2M of its secured promissory A-1 Note held by Streeterville Capital for…
Monitor for any subsequent 10-Q for cash runway update — with no new cash raised, the company's ability to service the Series B preferred dividend will pressure the balance sheet. The 8% annual…
All IMNN filing & press-release reports (13)
- S-1 reportOct 27, 2026
- 8-K reportOct 27, 2026
- 8-K reportOct 21, 2026
- 8-K reportSep 29, 2026
- 8-K reportAug 11, 2026
- 8-K reportAug 11, 2026
- 8-K reportJun 30, 2026
- 8-K reportJun 16, 2026
- 8-K reportJun 4, 2026
- 8-K reportMay 12, 2026
- 8-K reportMay 4, 2026
- 8-K reportMar 31, 2026
- PRESS-RELEASE reportMar 24, 2026